TRELEGY ELLIPTA FDA approval date

The FDA approved TRELEGY ELLIPTA on 18 Sep 2017.

FDA approval date
18 Sep 2017

Drug identity has not yet been verified against registry records

Also recorded as FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-09-18DayTRELEGY ELLIPTAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA209482", "applicant_as_listed_by_fda": "GLAXOSMITHKLINE", "brand_names": ["TRELEGY ELLIPTA"], "active_ingredients": ["FLUTICASONE FUROATE", "UMECLIDINIUM BROMIDE", "VILANTEROL TRIFENATATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170918", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026